209 — Birmingham, Alabama

209 is a clinical research site located in Birmingham, Alabama, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

209 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

• University of Alabama Birmingham - Main & Highlands
• University of Alabama Birmingham Lung Health Center
• University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic
• The University Of Alabama Of Birmingham
• University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility
• University of Alabama at Birmingham - School of Medicine-Cardiology ( Site 0153)
• University of Alabama Hospitals
• UAB Hospital /ID# 262565
• University of Alabama at Birmingham Women & Infants Center
• University of Alabama at Birmingham (UAB) - Center for Education & Research on Therapeutics of Musculoskeletal Disorders
• University of Alabama at Birmingham Endocrinology Department
• University of Alabama-The Kirklin Clinic

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 209?

209 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 209 conducted?

209 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 209 accredited by Crixeo Clinical Trials?

209 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 209?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.